Tadeusz Hawrot is the founder of the Psychedelic Access and Research European Alliance (PAREA), a Brussels-based initiative working to prepare Europe for the integration of psychedelic-assisted therapies into healthcare systems. In this interview, he reflects on the policy landscape, regulatory challenges, and the future of access to these emerging treatments in the EU.
Regulation and Control
Strong Military Budget for Europe, but Not at the Cost of Community Health and Safety – An Interview with Ganna Dovbakh
With the new EU drug strategy now adopted, key questions remain about its direction and implementation—especially the balance between public health, human rights, and security. We spoke with Anna Dovbakh, Chair of the Civil Society Forum on Drugs, about what the strategy means in practice and the role of civil society moving forward.
Dismantling Orbán’s System – Drugreporter interviewed by Arild Knutsen
As Hungary heads toward a pivotal election, the camera turns on two of its most prominent drug policy advocates. In this interview conducted by Arild Knutsen, Drugreporter founders Péter Sárosi and István Gábor Takács reflect on decades of activism—and explain why they are now taking their fight to the streets to challenge an increasingly repressive system.
Beyond Prohibition: Pavel Bém on Czechia’s Next Wave of Drug Policy Reform
We spoke with Pavel Bém, a Czech psychiatrist and former mayor of Prague in Vienna during the 69th session of the Commission on Narcotic Drugs (CND) about the country’s latest reforms—from cannabis regulation to psychedelic therapy—and what they mean for the future of drug policy in Europe.
Beyond the Nordic Paradox: How Harm Reduction Is Transforming Drug Policy in the North
Civil society and drug user activists push harm reduction reforms across the Nordic region – please watch the videos from a side event at the UN Commission on Narcotic Drugs (CND) and learn more about drug policy reform in Scandinavia!
Ukraine: To treat or not to treat
This DUNews video is dedicated to three key topics that today determine the future of Ukrainian drug policy and the healthcare system: the use of psychoactive substances in the treatment of various conditions, the full-fledged legalization of medical cannabis and the introduction of national standards, as well as the revision of Order No. 188 on minimum dosages of psychoactive substances based on European recommendations.
Building Hope: Substance Use in the Trades
Watch this new video series on how the opioid overdose crisis and Canada’s toxic drug supply impact people in the trades and construction sectors. A guest article by the co-producer of the films, Lorna Thomas, from Moms Stop the Harm.
Drug Policy Prospects in Trump’s Second Term – An Interview with Ethan Nadelmann
At the 28th Harm Reduction International Conference, we had the chance to speak with Ethan Nadelmann, founder of the Drug Policy Alliance in the United States, about the present and future of drug policy during Donald Trump’s second term as president. Watch the video here!
COSS MARTE: From Convict to Cannabis CEO in New York
Watch Drugreporter’s new video about Coss Marte, a former convict who, thanks to New York State’s Social Equity Program, now runs three cannabis retail shops and a gym where he employs other formerly incarcerated individuals.
Drug Policy at a Turning Point- Exploring the Evidence for Drug Law Reform | CND 2025 Sessions
This side event at the 68th CND explored the growing body of evidence highlighting the shortcomings of current drug policies to achieve their stated goals of safety, security, public health and ending stigma, while contributing to significant human rights violations. Organised by Norwegian Association for Humane Drug Policy.
